Pa Christopher W. James

Christopher W. James, PA has extensive experience in clinical operations and development. Christopher W. has held several leadership positions in various companies throughout their career. Since 2016, they have been the Vice President of Clinical Operations at Mesoblast Limited, where they strategically plan clinical trials, oversees program objectives and quality deliverables, and manages relationships with vendors. Prior to that, from 2014 to 2016, they served as the Vice President of Clinical Development at Relmada Therapeutics, Inc., where they coordinated operational aspects of multiple clinical programs and contributed to clinical development strategies. Christopher W. also worked as a Senior Director of Clinical Development at the same company. From 2012 to 2014, they were a Senior Consultant at Rapid Trials, focusing on optimizing the performance of clinical trial sites. Before that, they held positions at Cephalon, Inc. as the Director of Clinical Operations from 2007 to 2011 and at Adolor Corporation as the Director of Clinical Operations from 2001 to 2007. Christopher W. also founded and served as the President of Christopher James & Associates, Inc., a consulting firm that worked with GSK on the Bactroban Nasal clinical program. Additionally, they held various roles at Centocor from 1985 to 1996, including Director of Clinical Research Administration, Associate Director of Clinical Operations, Manager of Clinical Operations in Europe, and Manager of Clinical Operations in the US. Christopher W. James, PA has a strong background in clinical trials and extensive expertise in managing clinical development programs.

Christopher W. James, PA obtained a degree in Physician Assistant with a specialization in General Clinical Medicine and Surgery from Hahnemann Medical College. Prior to that, they attended Juniata College where they earned a Bachelor of Science degree. The specific field of study at Juniata College is not provided.